HEERMA PETER (Chief Commercial Officer) sold 1.5% of their position (2.17K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $101.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001789617-26-000003
Officer· Chief Commercial Officer
Since Oct 2019
+6.33K
Net shares
Net buyer
$101.4K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
12.75K acquired · 6.42K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.25K
Price / share
—
Trade value
—
% of position
3.1%
5/4/2026
138.61K→142.86K
Common Stock
Direct
Shares
−2.17K
Price / share
$46.65
Trade value
$101.42K
% of position
1.5%
5/5/2026
142.86K→140.68K
Total
Net shares
+2.08K
Net value
-$101.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | M · Option Exercise | +4.25K | — | — | 3.1% | 138.61K | 142.86K |
| Common Stock Direct | 5/5/2026 | S · Sale | −2.17K | $46.65 | $101.42K | 1.5% | 142.86K | 140.68K |
| Total | +2.08K | -$101.42K | ||||||
Derivative Transactions2
Performance-based restricted stock units
Direct
Converts to
Common Stock
8.50K shares
Shares
+8.50K
Strike price
Held after
8.50K
Exercisable
—
5/4/2026
Performance-based restricted stock units
Direct
Converts to
Common Stock
4.25K shares
Shares
−4.25K
Strike price
Held after
4.25K
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-based restricted stock units Direct | Common Stock8.50K shares | 5/4/2026 | A · Award | +8.50K | — | 8.50K | |
| Performance-based restricted stock units Direct | Common Stock4.25K shares | 5/4/2026 | M · Option Exercise | −4.25K | — | 4.25K |